Rituxan hycela 1,400 MG-23,400 11.7ML
Ended Awarded
- Contract number
- SPE2DB25FJY78
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,718
Award facts
- Contract value 100% obligated
- $3,718.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Rituxan Hycela (rituximab and hyaluronidase), a specialty pharmaceutical product used in oncology and immunology treatment regimens. The contract is valued at $3,718.02 with a firm fixed price structure and an ultimate completion date of October 8, 2025. This delivery order is non-set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability to meet federal procurement requirements for specialized medical products.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The Defense Logistics Agency utilizes this vehicle to ensure consistent pharmaceutical availability for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJY78?
SPE2DB25FJY78 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJY78 worth?
The government has obligated $3,718 on SPE2DB25FJY78.
Is contract SPE2DB25FJY78 an order under another contract?
Yes. SPE2DB25FJY78 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJY78 competed?
The extent of competition for SPE2DB25FJY78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award